Literature DB >> 16513519

The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.

Shyam Bhakta1, Ping Hong, Omer Koc.   

Abstract

BACKGROUND: Bone marrow mesenchymal stem cells (MSCs) can be used for myocardial repair following myocardial infarction. Increased expression of stromal cell-derived factor-1 (SDF-1) by an ischemic myocardium attracts CXCR4+ stem cells toward it. CXCR4, the receptor for SDF-1, is important in the migration, homing, and survival of hematopoietic stem cells. Although low levels of CXCR4 expression were found in minor subpopulations of cultured MSCs, most MSCs do not express CXCR4. To optimize the migration and survival of human MSCs, we expressed the CXCR4 gene in these cells using retroviral transduction.
MATERIALS AND METHODS: We isolated and cultured MSCs from healthy volunteers and transduced them with a retroviral vector containing either CXCR4 and green fluorescent protein (GFP; CXCR4/GFP vector) or GFP alone (control vector). Flow cytometry confirmed successful transduction and GFP and CXCR4 expression. We used a transwell migration system to study MSC migration to SDF-1. We used Annexin V and propidium iodide stains to assess cell survival before and after the survival challenge.
RESULTS: Flow cytometry showed that, on average, 83.4+/-17.7% of transduced MSCs expressed CXCR4. Compared with control MSCs, MSCs transduced with CXCR4 showed significantly more migration toward SDF-1, threefold greater at 3 h and more than fivefold greater at 6 h. Mesenchymal stem cells transduced with CXCR4 showed no significant difference in survival under normal to serum-deprived growth conditions.
CONCLUSION: Mesenchymal stem cells can be efficiently transduced to express CXCR4, and transduced MSCs migrate rapidly toward SDF-1. CXCR4 expression does not render survival advantage to MSCs under serum-deprived conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513519     DOI: 10.1016/j.carrev.2005.10.008

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  50 in total

1.  Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential.

Authors:  L-Y Sun; D-K Hsieh; W-S Syu; Y-S Li; H-T Chiu; T-W Chiou
Journal:  Cell Prolif       Date:  2010-10       Impact factor: 6.831

2.  Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Authors:  Naghmeh Ahmadian Kia; Ahmad Reza Bahrami; Marzieh Ebrahimi; Maryam M Matin; Zeinab Neshati; Mahmood Rais Almohaddesin; Naser Aghdami; Hamid Reza Bidkhori
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

3.  Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

Authors:  Na Li; Yue-Jin Yang; Hai-Yan Qian; Qing Li; Qian Zhang; Xiang-Dong Li; Qiu-Ting Dong; Hui Xu; Lei Song; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 4.  Genomic profiling of mesenchymal stem cells.

Authors:  Danijela Menicanin; P Mark Bartold; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cell Rev Rep       Date:  2009-02-18       Impact factor: 5.739

5.  Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.

Authors:  Marijke W Maijenburg; Christian Gilissen; Sara M Melief; Marion Kleijer; Kees Weijer; Anja Ten Brinke; Helene Roelofs; Claudia M Van Tiel; Joris A Veltman; Carlie J M de Vries; C Ellen van der Schoot; Carlijn Voermans
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

Review 6.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

7.  Up-regulation of CXCR4 in rat umbilical mesenchymal stem cells induced by serum from rat with acute liver failure promotes stem cells migration to injured liver tissue.

Authors:  Changqing Deng; Ailan Qin; Weifeng Zhao; Tingting Feng; Cuicui Shi; Tao Liu
Journal:  Mol Cell Biochem       Date:  2014-08-07       Impact factor: 3.396

8.  Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues.

Authors:  Vitali Alexeev; Adele Donahue; Jouni Uitto; Olga Igoucheva
Journal:  Cytotherapy       Date:  2013-02       Impact factor: 5.414

9.  Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.

Authors:  Dongsheng Zhang; Guo-Chang Fan; Xiaoyang Zhou; Tiemin Zhao; Zeeshan Pasha; Meifeng Xu; Yi Zhu; Muhammad Ashraf; Yigang Wang
Journal:  J Mol Cell Cardiol       Date:  2007-12-07       Impact factor: 5.000

Review 10.  Mesenchymal stromal cells: current understanding and clinical status.

Authors:  Husein K Salem; Chris Thiemermann
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.